Additionally, Xie et al. (2022) found that TK1 serves as a prognostic predictor in prostate cancer, correlating with poor outcomes, higher tumour stages, and promoting cancer progression, suggesting its potential diagnostic and therapeutic significance18. Here, TK1 is linked to prostate carcinoma.